Products Antibodies Monoclonal Antibodies Anti-IGFBP1 Monoclonal Antibody for WB, ELISA - P08833
Anti-IGFBP1 Monoclonal Antibody for WB, ELISA - P08833

Monoclonal Antibodies

Anti-IGFBP1 Monoclonal Antibody for WB, ELISA - P08833

Item Number : CM0002865

Price varies based on specs and customizations


Application
WB, ELISA
Cross Reactivity
Human
Protein Weight
28kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name IGFBP1 Rabbit mAb
Remarks/Alias AFBP, IBP1, PP12, IGF-BP25, hIGFBP-1, IGFBP1
Species Human
GeneID (Human) 3484
GeneID 3484
Immunogen A synthetic peptide corresponding to a sequence within amino acids 160-259 of human IGFBP1 (P08833).
Source Rabbit
Category Monoclonal Antibodies
Application WB, ELISA
Cross Reactivity Human
SWISS P08833
Protein Weight 28kDa
Shipping Ice bag

Biological Background: IGFBP1 Function and Localization

  • Insulin-like growth factor-binding protein 1 (IGFBP1), also known as placental protein 12 (PP12), is a secreted multifunctional protein that modulates the bioavailability of IGF1 and IGF2, thereby regulating cell migration, proliferation, differentiation, and apoptosis in a cell-type-specific manner. Related references: PMID:11397844 PMID:15972819
  • Through its RGD motif, IGFBP1 binds integrin ITGA5:ITGB1, promoting cell migration by activating focal adhesion kinase (FAK) and the mitogen-activated protein kinase (MAPK) pathway. Related references: PMID:7504269
  • IGFBP1 is highly expressed in the placenta and liver and is classified as a secreted protein following cleavage of its N-terminal signal peptide.
  • Post‑translational modifications include phosphorylation and disulfide bond formation, which may influence its binding affinity and functional activity.
  • The protein has a predicted molecular weight of approximately 28 kDa, consistent with the 27.9 kDa calculated from its amino acid sequence.
  • Structural studies (3D-structure) and direct protein sequencing have confirmed its primary sequence and folding, providing a basis for epitope mapping and antibody development.

Experimental Guidance and Technical Tips

  • The immunogen (aa 160–259) lies in a central region of human IGFBP1; this epitope may recognize both unmodified and post‑translationally modified forms.
  • For Western blot analysis, the expected band migrates near 28 kDa; validate antibody specificity using positive and negative cell lysates.
  • For ELISA, consider paired antibody formats (e.g., sandwich) and titrate concentrations to achieve optimal signal-to-noise ratios in your sample matrix.
  • As the antibody is recommended for human samples, cross-reactivity with other species should be tested if needed.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio offers comprehensive IVD raw material supply solutions, connecting diagnostic manufacturers and research laboratories with high-quality reagents like this anti‑IGFBP1 monoclonal antibody for growth factor and metabolic disorder research. Our capabilities include validated monoclonal/polyclonal antibodies, optimized matched antibody pairs, bulk ancillary reagents, and custom sourcing for rare targets. Partner with CamelBio to streamline your transition from early-stage assay development to reliable diagnostic application.

View more faqs for this product

Product Datasheet

Anti-IGFBP1 Monoclonal Antibody for WB, ELISA - P08833


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!